“An In-Silico and In-Vitro Study of Imatinib and Naringin Combination for Inhibiting P-Glycoprotein and Delaying Drug Resistance in Chronic Myeloid Leukemia” (2023) Asian Journal of Pharmaceutics (AJP), 17(2). doi:10.22377/ajp.v17i2.4859.